Transcenta Holding Ltd. is a clinical stage global biopharmaceutical company, which engages in discovery, research, development, and manufacturing of differentiated antibody therapies in therapeutic areas with high unmet medical needs. The company is headquartered in Suzhou, Anhui and currently employs 171 full-time employees. The company went IPO on 2021-09-29. The firm's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The firm also provides contract development and manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.
06628.HK stock price ended at $2.36 on 목요일, after rising 0.43%
On the latest trading day Feb 12, 2026, the stock price of 06628.HK rose by 0.43%, climbing from $2.30 to $2.36. During the session, the stock saw a volatility of 7.93%, with prices oscillating between a daily low of $2.27 and a high of $2.45. Notably, trading volume dropped by 29.5K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 431.0K shares were traded, equating to a market value of approximately $1.0B.
06628.HK 기술적 시그널
기술적 시그널 요약
구매 신호 3
중립 신호 2
매도 신호 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
06628.HK은 현재 3개의 매수 신호와 2개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 0.43%입니다. 전반적으로 기술적 지표들은 중기적으로 Buy 전망을 나타내고 있습니다.
06628.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 06628.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.